All results
1 results for randomized phase iii clinical trial evaluating post mastectomy chestwall and regional
-
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Comp
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who…
- Ages
- 18 Years - N/A
- Sexes
- All